OncoType Dx: Prediciendo la Recurrencia del Cáncer

This article has been moved to a new location
View article


7 Tips for Giving Smart on #givingtuesday
by Christina Bach, MSW, LCSW, OSW-C
November 25, 2015

Related News

FDA Approves Keytruda for Advanced NSCLC

Oct 5, 2015

Approved for use with PD-L1 IHC 22C3 pharmDx test

High False-Negative Rate for HER2 Status Using Oncotype DX

Oct 13, 2011

HER2 status in breast cancer with RT-PCR assay is discordant with IHC/FISH results


Aug 31, 2010